Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes
- PMID: 25087609
- PMCID: PMC4129407
- DOI: 10.1016/j.ajhg.2014.07.002
Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes
Abstract
Psoriasis vulgaris (PsV) risk is strongly associated with variation within the major histocompatibility complex (MHC) region, but its genetic architecture has yet to be fully elucidated. Here, we conducted a large-scale fine-mapping study of PsV risk in the MHC region in 9,247 PsV-affected individuals and 13,589 controls of European descent by imputing class I and II human leukocyte antigen (HLA) genes from SNP genotype data. In addition, we imputed sequence variants for MICA, an MHC HLA-like gene that has been associated with PsV, to evaluate association at that locus as well. We observed that HLA-C(∗)06:02 demonstrated the lowest p value for overall PsV risk (p = 1.7 × 10(-364)). Stepwise analysis revealed multiple HLA-C(∗)06:02-independent risk variants in both class I and class II HLA genes for PsV susceptibility (HLA-C(∗)12:03, HLA-B amino acid positions 67 and 9, HLA-A amino acid position 95, and HLA-DQα1 amino acid position 53; p < 5.0 × 10(-8)), but no apparent risk conferred by MICA. We further evaluated risk of two major clinical subtypes of PsV, psoriatic arthritis (PsA; n = 3,038) and cutaneous psoriasis (PsC; n = 3,098). We found that risk heterogeneity between PsA and PsC might be driven by HLA-B amino acid position 45 (Pomnibus = 2.2 × 10(-11)), indicating that different genetic factors underlie the overall risk of PsV and the risk of specific PsV subphenotypes. Our study illustrates the value of high-resolution HLA and MICA imputation for fine mapping causal variants in the MHC.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.Ann Rheum Dis. 2017 Oct;76(10):1774-1779. doi: 10.1136/annrheumdis-2017-211414. Epub 2017 Aug 18. Ann Rheum Dis. 2017. PMID: 28821532 Free PMC article.
-
Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population.Hum Immunol. 2001 Jun;62(6):632-8. doi: 10.1016/s0198-8859(01)00242-7. Hum Immunol. 2001. PMID: 11390038
-
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis.Arthritis Rheum. 1999 May;42(5):1010-6. doi: 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H. Arthritis Rheum. 1999. PMID: 10323458
-
Genetics of psoriasis and psoriatic arthritis.Reumatismo. 2007;59 Suppl 1:25-7. doi: 10.4081/reumatismo.2007.1s.25. Reumatismo. 2007. PMID: 17828355 Review.
-
Associations between the major histocompatibility complex class I chain-related gene A transmembrane (MICA-TM) polymorphism and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis.Rheumatol Int. 2014 Jan;34(1):117-23. doi: 10.1007/s00296-013-2849-2. Epub 2013 Aug 22. Rheumatol Int. 2014. PMID: 23974432 Review.
Cited by
-
Exploration of the causality of frailty index on psoriasis: A Mendelian randomization study.Skin Res Technol. 2024 Mar;30(3):e13641. doi: 10.1111/srt.13641. Skin Res Technol. 2024. PMID: 38426414 Free PMC article.
-
Identifying the genetic associations among the psoriasis patients in eastern India.J Hum Genet. 2024 Feb 27. doi: 10.1038/s10038-024-01227-8. Online ahead of print. J Hum Genet. 2024. PMID: 38409498
-
Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution.Nat Genet. 2023 Dec;55(12):2255-2268. doi: 10.1038/s41588-023-01586-6. Epub 2023 Nov 30. Nat Genet. 2023. PMID: 38036787 Free PMC article.
-
Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis.Cell Rep Med. 2023 Jul 18;4(7):101114. doi: 10.1016/j.xcrm.2023.101114. Cell Rep Med. 2023. PMID: 37467720 Free PMC article.
-
Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility.Am J Hum Genet. 2023 Jul 6;110(7):1138-1161. doi: 10.1016/j.ajhg.2023.05.013. Epub 2023 Jun 19. Am J Hum Genet. 2023. PMID: 37339630 Free PMC article.
References
-
- Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N. Engl. J. Med. 2009;361:496–509. - PubMed
-
- Christophers E. Psoriasis—epidemiology and clinical spectrum. Clin. Exp. Dermatol. 2001;26:314–320. - PubMed
-
- Veal C.D., Capon F., Allen M.H., Heath E.K., Evans J.C., Jones A., Patel S., Burden D., Tillman D., Barker J.N., Trembath R.C. Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am. J. Hum. Genet. 2002;71:554–564. - PMC - PubMed
-
- Helms C., Saccone N.L., Cao L., Daw J.A., Cao K., Hsu T.M., Taillon-Miller P., Duan S., Gordon D., Pierce B. Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR. Hum. Genet. 2005;118:466–476. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR050266/AR/NIAMS NIH HHS/United States
- 1R01AR062886/AR/NIAMS NIH HHS/United States
- R01 AR042742/AR/NIAMS NIH HHS/United States
- CAPMC/ CIHR/Canada
- 5U01GM092691-04/GM/NIGMS NIH HHS/United States
- R01AR050511/AR/NIAMS NIH HHS/United States
- 1R01AR063759-01A1/AR/NIAMS NIH HHS/United States
- R01AR062382/AR/NIAMS NIH HHS/United States
- U01 GM092691/GM/NIGMS NIH HHS/United States
- R01 AR050511/AR/NIAMS NIH HHS/United States
- R01 AR063759/AR/NIAMS NIH HHS/United States
- R01 AR062886/AR/NIAMS NIH HHS/United States
- R01 AR065183/AR/NIAMS NIH HHS/United States
- R01 AR063611/AR/NIAMS NIH HHS/United States
- 2R01AR050266/AR/NIAMS NIH HHS/United States
- R01AR042742/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
